GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Asset Turnover

Hemagen Diagnostics (Hemagen Diagnostics) Asset Turnover : 0.35 (As of Sep. 2012)


View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Hemagen Diagnostics's Revenue for the three months ended in Sep. 2012 was $0.88 Mil. Hemagen Diagnostics's Total Assets for the quarter that ended in Sep. 2012 was $2.48 Mil. Therefore, Hemagen Diagnostics's Asset Turnover for the quarter that ended in Sep. 2012 was 0.35.

Asset Turnover is linked to ROE % through Du Pont Formula. Hemagen Diagnostics's annualized ROE % for the quarter that ended in Sep. 2012 was 18.65%. It is also linked to ROA % through Du Pont Formula. Hemagen Diagnostics's annualized ROA % for the quarter that ended in Sep. 2012 was -26.27%.


Hemagen Diagnostics Asset Turnover Historical Data

The historical data trend for Hemagen Diagnostics's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Asset Turnover Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.43 1.28 1.47 1.64 1.52

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.40 0.43 0.37 0.35

Competitive Comparison of Hemagen Diagnostics's Asset Turnover

For the Biotechnology subindustry, Hemagen Diagnostics's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemagen Diagnostics's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Asset Turnover falls into.



Hemagen Diagnostics Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Hemagen Diagnostics's Asset Turnover for the fiscal year that ended in Sep. 2012 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Sep. 2012 )/( (Total Assets (A: Sep. 2011 )+Total Assets (A: Sep. 2012 ))/ count )
=4.042/( (2.888+2.443)/ 2 )
=4.042/2.6655
=1.52

Hemagen Diagnostics's Asset Turnover for the quarter that ended in Sep. 2012 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2012 )/( (Total Assets (Q: Jun. 2012 )+Total Assets (Q: Sep. 2012 ))/ count )
=0.876/( (2.521+2.443)/ 2 )
=0.876/2.482
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Hemagen Diagnostics  (OTCPK:HMGN) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Hemagen Diagnostics's annulized ROE % for the quarter that ended in Sep. 2012 is

ROE %**(Q: Sep. 2012 )
=Net Income/Total Stockholders Equity
=-0.652/-3.4955
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.652 / 3.504)*(3.504 / 2.482)*(2.482/ -3.4955)
=Net Margin %*Asset Turnover*Equity Multiplier
=-18.61 %*1.4118*-0.7101
=ROA %*Equity Multiplier
=-26.27 %*-0.7101
=18.65 %

Note: The Net Income data used here is four times the quarterly (Sep. 2012) net income data. The Revenue data used here is four times the quarterly (Sep. 2012) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Hemagen Diagnostics's annulized ROA % for the quarter that ended in Sep. 2012 is

ROA %(Q: Sep. 2012 )
=Net Income/Total Assets
=-0.652/2.482
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.652 / 3.504)*(3.504 / 2.482)
=Net Margin %*Asset Turnover
=-18.61 %*1.4118
=-26.27 %

Note: The Net Income data used here is four times the quarterly (Sep. 2012) net income data. The Revenue data used here is four times the quarterly (Sep. 2012) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Hemagen Diagnostics Asset Turnover Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Executives
Howard F Curd director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines